Skip to main content

Table 2 Association between STK25 expression and clinicopathological parameters in patients with HCC in TCGA

From: STK25 enhances hepatocellular carcinoma progression through the STRN/AMPK/ACC1 pathway

Variables

STK25 expression

χ2

P

Low (n = 290) (%)

High (n = 75) (%)

Gender

  

5.217

0.022

 Male

188 (64.8)

59 (78.7)

  

 Female

102 (35.2)

16 (21.3)

  

Age

  

1.354

0.245

≦65

176 (60.7)

51 (68.0)

  

 > 65

114 (39.3)

24 (32.0)

  

Child–Pugh grade

  

3.909

0.142

 A

179 (61.7)

37 (49.3)

  

 B–C

17 (5.9)

5 (6.7)

  

 Unknow

94 (32.4)

33 (44.0)

  

TNM stage

  

10.618

0.030

 I

139 (47.9)

31 (41.3)

  

 II

70 (24.1)

14 (18.7)

  

 III

56 (19.3)

27 (36.0)

  

 IV

4 (1.4)

0 (0.0)

  

 Unknow

21 (7.3)

3 (4.0)

  

Histologic grade

  

3.217

0.200

 G1–G2

177 (61.0)

53 (70.6)

  

 G3–G4

108 (37.2)

22 (29.4)

  

 Unknow

5 (1.8)

0 (0.0)

  

Vascular invasion

  

9.660

0.008

 No

172 (59.3)

33 (44.0)

  

 Yes

83 (28.6)

23 (30.7)

  

 Unknow

35 (12.1)

19 (25.3)

  

Ishak score

  

2.884

0.236

 0–4

111 (38.3)

21 (28.0)

  

 5–6

58 (20.0)

19 (25.3)

  

 Unknow

121 (41.7)

35 (46.7)

  
  1. Statistically significant p values are given in bold, P < 0.05